The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancer
- PMID: 15309887
- DOI: 10.1023/b:ddas.0000034558.78747.98
The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancer
Abstract
Bile acids have been implicated in the development of colorectal cancers. We investigated the expression of the transcription factor regulated by bile acids, farnesoid X receptor (FXR), as well as other components of this pathway in human colorectal tumors and cell lines. The most significant changes were a decrease in FXR mRNA levels in adenomas (5-fold average) and carcinomas (10 fold average) and an increase in peroxisome proliferator activated receptor-gamma (2-fold average). FXR was not expressed in undifferentiated colon adenocarcinoma SW480 cells and metastasis derived SW620 cells. In Caco-2 and HT-29 cells, the level of FXR expression increased with the degree of differentiation. Intestinal bile acid binding protein was activated by chenodeoxycholic acid and the synthetic FXR agonist GW4064 in Caco-2 and HT-29 but not in SW cells unless FXR was transfected. The down-regulation of the nuclear receptor FXR in colon cancer might be of clinical and pharmacological importance.
Similar articles
-
Bile salt excretory pump: biology and pathobiology.J Pediatr Gastroenterol Nutr. 2006 Jul;43 Suppl 1:S10-6. doi: 10.1097/01.mpg.0000226385.71859.5f. J Pediatr Gastroenterol Nutr. 2006. PMID: 16819395 Review.
-
Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.Mol Endocrinol. 2003 Feb;17(2):259-72. doi: 10.1210/me.2002-0120. Mol Endocrinol. 2003. PMID: 12554753
-
Bile acid-stimulated expression of the farnesoid X receptor enhances the immune response in Barrett esophagus.Am J Gastroenterol. 2008 Jun;103(6):1510-6. doi: 10.1111/j.1572-0241.2008.01908.x. Epub 2008 May 28. Am J Gastroenterol. 2008. PMID: 18510604
-
Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity.Gastroenterology. 2004 Mar;126(3):756-64. doi: 10.1053/j.gastro.2003.12.013. Gastroenterology. 2004. PMID: 14988830
-
The role of the enterohepatic circulation of bile salts and nuclear hormone receptors in the regulation of cholesterol homeostasis: Bile salts as ligands for nuclear hormone receptors.Can J Gastroenterol. 2003 Apr;17(4):265-71. doi: 10.1155/2003/190784. Can J Gastroenterol. 2003. PMID: 12704471 Review.
Cited by
-
Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention.World J Gastroenterol. 2014 May 28;20(20):6055-72. doi: 10.3748/wjg.v20.i20.6055. World J Gastroenterol. 2014. PMID: 24876728 Free PMC article. Review.
-
A tea catechin, epigallocatechin-3-gallate, is a unique modulator of the farnesoid X receptor.Toxicol Appl Pharmacol. 2012 Jan 15;258(2):268-74. doi: 10.1016/j.taap.2011.11.006. Epub 2011 Dec 4. Toxicol Appl Pharmacol. 2012. PMID: 22178739 Free PMC article.
-
Role of bile acids in colon carcinogenesis.World J Clin Cases. 2018 Nov 6;6(13):577-588. doi: 10.12998/wjcc.v6.i13.577. World J Clin Cases. 2018. PMID: 30430113 Free PMC article. Review.
-
Oxysterols and Gastrointestinal Cancers Around the Clock.Front Endocrinol (Lausanne). 2019 Jul 17;10:483. doi: 10.3389/fendo.2019.00483. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31379749 Free PMC article. Review.
-
Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1.Sci Rep. 2017 Apr 4;7(1):591. doi: 10.1038/s41598-017-00698-4. Sci Rep. 2017. PMID: 28377627 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources